Bolt Biotherapeutics, Inc. · NASDAQ:BOLT
Nemec Sarah bought 509 and sold 7,842 Bolt Biotherapeutics, Inc. shares (Form 4)
Traded Jun 5 to Sep 18, 2026 · Filed Sep 21, 2026
From Jun 5 to Sep 18, 2026, Nemec Sarah (Senior VP, Finance and PAO) bought 509 and sold 7,842 Bolt Biotherapeutics, Inc. shares, leaving 17,082 shares. Filed Sep 21, 2026 (Form 4).
- Bought
- 509 shares (US$1,975 at US$3.88)
- Sold
- 7,842 shares (US$26,089 at an average US$3.33)
- Holding after
- 17,082 shares
- Trading plan
- No
- Role
- Senior VP, Finance and PAO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 5, 2026 | Common Stock | Buy | 509 | US$3.88 | 1,924 | Direct |
| Sep 16, 2026 | Common Stock | Sale | 843 | US$3.77 | 24,081 | Direct |
| Sep 17, 2026 | Common Stock | Sale | 2,922 | US$3.32 | 21,159 | Direct |
| Sep 18, 2026 | Common Stock | Sale | 4,077 | US$3.24 | 17,082 | Direct |
Source
Related
- Bolt Biotherapeutics, Inc.
- Nemec Sarah
- Bolt Biotherapeutics, Inc. shareholders
- Form 4 · Yonehiro Grant · Sep 21, 2026
- Form 4 · Quinn William P. · Sep 21, 2026
- Schedule 13G · Renaissance Technologies LLC · Aug 13, 2026
- Schedule 13D/A · Nan Fung Group Holdings Ltd · Feb 26, 2026
- Schedule 13D/A · Nan Fung Group Holdings Ltd · Feb 17, 2026